person

PARENT P.

Country
France
Department
Centre d'investigation clinique (CIC) à l'Institut Coeur Poumon

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
10
Sites with multiple studies

Has run more than one trial at 10 of 114 partner sites.

Specializations

Gastrointestinal Oncology

The investigator specializes in treating advanced gastrointestinal malignancies, with particular emphasis on colorectal cancer and pancreatic ductal adenocarcinoma. Their research extends to innovative treatments for gastric and gastroesophageal junction cancers.

  • KRAS G12C mutation-targeted therapies
  • FGFR2b-expressing tumors
  • Advanced pancreatic cancer treatments

Their work includes evaluating novel therapeutic combinations and targeted approaches for patients with specific molecular alterations.

Thoracic Oncology

The investigator focuses on developing treatments for non-small cell lung cancer, particularly in cases involving specific molecular markers. Their expertise includes studying novel therapeutic approaches for MAPK pathway mutations.

  • KRAS G12C-mutant NSCLC
  • Targeted therapy combinations
  • Advanced solid tumor treatments

Their research encompasses innovative combination strategies for treatment-naive and previously treated patients.

Precision Oncology

The investigator specializes in molecular-targeted therapies across multiple tumor types, with particular attention to MAPK pathway alterations and specific genetic mutations.

  • Biomarker-driven treatment approaches
  • Novel drug combinations
  • Resistance mechanism studies

Their work includes investigating innovative treatment strategies for patients with specific genetic alterations across various solid tumors.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.